T1	Participants 101 412	The treatment of gastrointestinal cancer was studied in 20 phase I, II, and III clinical trials from 1979 to 1983 at 30 member institutions of the Southeastern Cancer Study Group (SECSG). These studies used both new and commercially available drugs, as well as surgery and/or radiation therapy in 1,087 patients
